New-Onset Isolated Asymptomatic Papilledema in Two Patients Treated With Recombinant Growth Hormone

Wilton P . Adverse events reported in KIGS. In: Ranke M Reiter E , eds. Growth Hormone Therapy in Pediatrics—20 Years of KIGS. Basel, Switzerland: Karger; 2007:432-441.

Obinata K Kamata A Kinoshita K et al . Prolonged intracranial hypertension after recombinant growth hormone therapy due to impaired CSF absorption. Clin Pediatr Endocrinol. 2010;19:39-44.

Malozowski S Tanner LA Wysowski DK Fleming GA Stadel BV. Benign intracranial hypertension in children with growth hormone deficiency treated with growth hormone. J Pediatr. 1995;126:996-999.

Wyatt D. Lessons from the national cooperative growth study. Eur J Endocrinol. 2004;151(suppl 1):S55-S59.

Koller EA Stadel BV Malozowski SN. Papilledema in 15 renally compromised patients treated with growth hormone. Pediatr Nephrol. 1997;11:451-454.

Rogers AH Rogers GL Bremer DL McGregor ML. Pseudotumor cerebri in children receiving recombinant human growth hormone. Ophthalmology. 1999;106:1186-1189.

Vischi A Guerriero S Giancipoli G Lorusso V Sborgia G. Delayed onset of pseudotumor cerebri syndrome 7 years after starting human recombinant growth hormone treatment. Eur J ophthalmol. 2006;16:178-180.

Bedell AJ. Papilledema without increased intracranial pressure. Trans Am Ophthalmol Soc. 1941;39:242-261.

Lordereau-Richard I Roger M Chaussain JL. Transient bilateral papilloedema in a 10-year-old boy treated with recombinant insulin-like growth factor I for growth hormone receptor deficiency. Acta Paediatr Suppl. 1994;399:152.

Crock PA McKenzie JD Nicoll AM et al . Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand. Acta Paediatr. 1998;87:381-386.

Collett-Solberg PF Liu GT Satin-Smith M Katz LL Moshang T Jr. Pseudopapilledema and congenital disc anomalies in growth hormone deficiency. J Pediatr Endocrinol & Metab. 1998;11:261-265.

Francois I Casteels I Silberstein J Casaer P de Zegher F. Empty sella, growth hormone deficiency and pseudotumour cerebri: effect of initiation, withdrawal and resumption of growth hormone therapy. Eur J Pediatr. 1997;156:69-70.

Besch D Makowski C Steinborn MM Bonfig W Sadowski B. Visual loss without headache in children with pseudotumor cerebri and growth hormone treatment. Neuropediatrics. 2013;44:203-207.

Skau M Sander B Milea D Jensen R. Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol. 2011;258:277-283.